双特异性磷酸酶9通过抑制ASK1在小鼠中预防非酒精性脂肪性肝病
该研究利用肝特异性Dusp9敲除和转基因小鼠,发现Dusp9是高脂饮食诱导的肝脏脂肪变性和炎症反应的关键抑制因子,其缺失加重高脂高胆固醇饮食诱导的肝纤维化。Dusp9通过阻断ASK1磷酸化及下游p38和JNK信号激活发挥作用,提示Dusp9可能是治疗NAFLD和NASH的潜在靶点。
要点
- Dusp9是高脂饮食诱导的肝脏脂肪变性和炎症反应的关键抑制因子。
- Dusp9缺失加重高脂高胆固醇饮食诱导的肝纤维化。
- Dusp9通过阻断ASK1磷酸化及下游p38和JNK信号激活发挥作用。
核心结论
- 肝细胞Dusp9以ASK1依赖的方式预防小鼠NAFLD和NASH进展,包括脂质蓄积、糖代谢紊乱以及炎症和肝纤维化增强。
研究设计与样本
- 研究使用肝特异性Dusp9敲除(Dusp9-CKO)小鼠和Dusp9转基因小鼠。
- 研究涉及高脂饮食和高脂高胆固醇饮食诱导的模型。
主要发现
- Dusp9是高脂饮食诱导的肝脏脂肪变性和炎症反应的关键抑制因子。
- Dusp9缺失加重高脂高胆固醇饮食诱导的肝纤维化。
- Dusp9通过阻断ASK1磷酸化及后续p38和c-Jun NH2末端激酶信号激活发挥作用。
临床怎么用
- 作者认为Dusp9可能是治疗NAFLD和NASH的有前景的治疗靶点。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic fatty liver disease (NAFLD), ranging from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH), is the leading cause of chronic liver diseases. Until now, no medications for NAFLD have been approved by relevant governmental agencies. Dual-specificity phosphatase 9 (Dusp9) is a member of the DUSP protein family. Dusp9 is expressed in insulin-sensitive tissues, and its expression may be modified with the development of insulin resistance (IR). However, the molecular targets and mechanisms of Dusp9 action on NAFLD and NASH remain poorly understood. In this study, using conditional liver-specific Dusp9-knockout (Dusp9-CKO) mice and Dusp9-transgenic mice, we showed that Dusp9 was a key suppressor of high-fat diet-induced hepatic steatosis and inflammatory responses and that Dusp9 deficiency aggravated high-fat high-cholesterol diet-induced liver fibrosis. Dusp9 was shown to exert its effects by blocking apoptosis signal-regulating kinase 1 (ASK1) phosphorylation and the subsequent activation of p38 and c-Jun NH2-terminal kinase signaling. Conclusion: Hepatocyte Dusp9 prevents NAFLD and NASH progression in mice, including lipid accumulation, glucose metabolism disorders, and enhanced inflammation and liver fibrosis, in an ASK1-dependent manner; these findings suggest that Dusp9 may be a promising therapeutic target for the treatment of NAFLD and NASH.
引用
- Ye P, Xiang M, Liao H, et al. Dual-Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression. Hepatology. 2018. PMID: 30063256. doi:10.1002/hep.30198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。